Can you help me understand the 80%+ rise in share price (at the time of this post) for ANDS today? So they got approval to do a longer Phase 2 study. Let's keep in mind that this is a study for which they could not garner a partner for given the safety issues that cropped up in the Phase 1b. How does just the fact that they got approval to run a longer trial have any bearing on the actual results of the trial? Isn't this just another case of Zebra's law where they have to run this trial because they have nothing left in the pipeline? The safety concerns are still there. As such, an 80% rise in share price seems perplexing.
Market Data 
Markets 
AI
